Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
/
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
OptiCept Technologies AB is an innovative company specializing in technology solutions that enhance the quality and shelf life of various perishable products. The company's primary function revolves around the development of unique technologies for the treatment and packaging of fresh produce, flowers, and other biological materials. By employing patented methods such as vacuum infusion and oxygen management, OptiCept Technologies aims to improve the preservation and aesthetic appeal of these products. Operating at the intersection of technology and agriculture, OptiCept Technologies impacts sectors such as food distribution, horticulture, and biotechnology. Its solutions cater to the needs of producers, retailers, and consumers demanding longer-lasting freshness and reduction in food waste. In the financial market, OptiCept Technologies holds significance due to its innovative approach and potential to disrupt traditional preservation methods, contributing to sustainable practices and efficiency in global supply chains. Headquartered in Sweden, the company continues to build on its technological expertise to support the agricultural and food industries' transition towards more sustainable and efficient practices.
kr 0.23
kr 0.01 (-5.51%)
Live · 11:05 PM · Twelve Data
The business is unprofitable at the operating level (-312.11% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue up 54.1% YoY with margins expanding 8.5pp.
ROIC dropped from -12.01% to -19.08%, capital efficiency is deteriorating. Negative free cash flow of -kr 54M. The business is consuming cash, not generating it.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
kr 30M
▲ +54.1% YoY
Net Income (TTM)
-kr 102M
▼ -62.5% YoY
Op. Margin
-291.89%
▲ +8.5pp YoY
ROIC
-19.08%
▼ -7.1pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-kr 49M
▲ +9.0% YoY
Op. Cash Flow (TTM)
-kr 48M
▲ +9.0% YoY
Net Debt
kr 44M
Cash & Equiv.
kr 3M
3Y CAGR: +37.4%
Continue Research
OptiCept Technologies AB (OPTI.XSTO)'s valuation is best read against its own history, its peers, and the growth its price implies. A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, OptiCept Technologies AB scores 30/100 on Intrinsiqq's quality scorecard, weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from SEC filings; read the full . This is analysis, not investment advice.
OptiCept Technologies AB scores 30 out of 100 on Intrinsiqq's quality score, a weighted blend of 6 metrics each scored 0 to 100, which makes it a lower-quality business on these measures. Recent fundamentals include a -291.9% operating margin and a -19.1% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
That depends on valuation and quality together, not either alone. you should weigh OPTI.XSTO's valuation and scores 30/100 on quality (lower-quality). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.